Navigation Links
PLC Systems Files IDE Supplement to Begin Pivotal Study of RenalGuard(TM) and Provides Update on Planned Development Timeline
Date:2/15/2008

he pivotal trial is an important milestone. We are working diligently to recruit sites for the pivotal trial, and anticipate continued positive interest from medical specialists who currently have no proven method to address the continued high incidence of CIN in their patients. At the same time, we are also pleased by our progress with RenalGuard in Europe. We anticipate that the planned Italian clinical trial of RenalGuard at the Centro Cardiologico Monzino (CCM-University of Milan) will begin in March, following receipt of final approval from the ethics committee at the institution. We expect that this effort, under the leadership of two renowned worldwide experts on CIN, Drs. Antonio Bartorelli and Giancarlo Marenzi, will provide additional confidence to early adopters who recognize the potential benefits of utilizing the unique fluid balancing capabilities of the RenalGuard System in a cath lab setting during cardiovascular imaging procedures for patients at higher risk of CIN. This study is expected to include 120 patients, and compare RenalGuard against overnight hydration, the prevalent standard of care currently in Europe."

In addition to the CCM study, PLC continues to work towards a limited launch of RenalGuard in Italy, following receipt of CE Mark certification in late 2007. The initial launch will focus on early adopters in that country at approximately 10 sites in Italy. A more expanded all-European Union launch for RenalGuard is contemplated for 2009.

Contrast-Induced Nephropathy

Approximately seven million patients worldwide undergo interventional cardiovascular therapeutic and diagnostic imaging procedures each year. Contrast-Induced Nephropathy, or CIN, is a major and growing problem due to the increasing number of older patients, diabetics and patients with pre- existing renal impairment -- all of whose conditions make them at risk for CIN when they require interventional procedures that use radiographic contrast media. CIN i
'/>"/>

SOURCE PLC Systems Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. New study shows extent of harmful human influences on global ecosystems
2. Microsoft Announces the Amalga Family of Health Enterprise Systems
3. Thomson Healthcares Clinical Xpert Navigator Tops KLAS Annual Performance Ranking in Mobile Data Systems for Sixth Consecutive Year
4. Harman/Becker Automotive Systems Completes Initial Deployments of Visiprise Integrated Manufacturing Execution
5. Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Year Ended December 31, 2007
6. Microsoft Dynamics CRM 4.0 Users now can include Telephony and Call Recording features by adding ConversationPRO(TM) from VoiceGate, a Division of IgeaCare Systems Inc.
7. Keystone Human Services Acquires Impact Systems, Inc.
8. IDC Digital radiography systems Ranked #1 for third consecutive quarter
9. OxySure(R) Systems, Inc. Named to 2008 Worlds Best Technologies (WBT) List For its Unique, Safe and Easy to Use Portable Emergency Oxygen Generator, Which Provides Medical Oxygen Without the Need for Compressed Tanks
10. Cardicas C-Port Anastomosis Systems for Coronary Artery Bypass Graft Procedures to be Used to Train Cardiothoracic Surgeons at Society of Thoracic Surgeons (STS) University
11. Sonian Introduces the Most Affordable, Reliable and Scaleable Email Archiving Solution for All Messaging Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... private insurance could boost the ranks of the uninsured , , ... going without health insurance for a period of time is ... survey has found. , These gaps in coverage, however, are ... insurance through public programs, such as Medicaid. , "The bad ...
... (Nasdaq: NUVA ), a medical device company ... for the spine, announced today that it has agreed ... focused on clinical approval of the PCM(R) cervical disc ... strategic acquisition allows NuVasive the potential to accelerate its ...
... ResMed Inc. (NYSE: RMD ), announced today ... results for the third quarter and nine months of fiscal ... ResMed,s results will be issued after 1:00 p.m. Pacific Time ... to review its results, market trends, and future outlook.The conference ...
... mean a 10% decline in information recall, scientists say, ... teens go on a binge drinking episode, they may ... in their brain, a new MRI-based study suggests. , ... cells, the researchers said. This means that damage caused ...
... -- Revenues of $73.8 million, -- Gross ... of $12.8 million or $0.27 per diluted share, , ... "Lotus" or the,"Company") today reported its strong 2008 results with ... total net revenues; gross profit,increasing to $33.4 million, up 44% ...
... Ethicon Endo-Surgery today announced the ... are featured in 15 studies being presented at ... Surgeons (SAGES) Annual Meeting. Setting the stage for ... preliminary experiences with the devices during, or with ...
Cached Medicine News:Health News:More Americans Experiencing Gaps in Health Coverage 2Health News:More Americans Experiencing Gaps in Health Coverage 3Health News:NuVasive Announces Acquisition of Cervical Total Disc Replacement Device 2Health News:NuVasive Announces Acquisition of Cervical Total Disc Replacement Device 3Health News:NuVasive Announces Acquisition of Cervical Total Disc Replacement Device 4Health News:ResMed Announces Conference Call and Webcast to Discuss Third Quarter 2009 Results 2Health News:Binge Drinking May Damage Teens' Brains 2Health News:Binge Drinking May Damage Teens' Brains 3Health News:Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results 2Health News:Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results 3Health News:Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results 4Health News:Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results 5Health News:Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results 6Health News:Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results 7Health News:Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results 8Health News:Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results 9Health News:Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results 10Health News:Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results 11Health News:Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results 12Health News:Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results 13Health News:Ethicon Endo-Surgery Novel Investigational Notes and SSL Devices Featured in 15 Presentations at Sages 2Health News:Ethicon Endo-Surgery Novel Investigational Notes and SSL Devices Featured in 15 Presentations at Sages 3Health News:Ethicon Endo-Surgery Novel Investigational Notes and SSL Devices Featured in 15 Presentations at Sages 4
(Date:12/17/2014)... Dec. 17, 2014  IGI Laboratories, Inc. (NYSE MKT: ... of its offering of $125 million aggregate principal amount ... The Notes were offered and sold only to qualified ... Act of 1933, as amended (the "Securities Act"). ... of 3.75% per year, payable semiannually in arrears on ...
(Date:12/17/2014)... PCCA received the Autism Hope Alliance,s ... program seal for best practices in meeting needs ... practices, materials and goods that meet strict criteria ... affected by autism often have unique physical or ... found in food and medicine – for instance ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... the "Electrocardiogram (ECG) Devices - Global Trends, Estimates ... http://photos.prnewswire.com/prnh/20130307/600769 Global ... million by 2016. The North America ... market share while Europe claims ...
Breaking Medicine Technology:IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 2Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 3Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 4
... biotechnology,company Crucell N.V., the Aeras Global TB Vaccine ... present a progress update,and immunology data from a ... "Tuberculosis Vaccines for the World" conference (Atlanta,Georgia, April ... Worcester, South,Africa and launched in May 2007, is ...
... Officer, to present interim results of the ... Injury, HOPKINTON, Mass., April 9, 2008 Alseres,Pharmaceuticals, ... 15, 2008, Dr.,Mark Hurtt, Chief Medical Officer, will discuss ... panel on Spinal Cord Injury Research,during a congressional briefing ...
Cached Medicine Technology:Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 2Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 3Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 4Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 5Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 6Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008 2Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008 3Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008 4
... Finntips have been designed to optimize the ... of our tip products is widely recognized ... range has been extended over the years ... standard and special tips including filter tips, ...
The BioCheck LH ELISA is intended for the quantitative determination of luteinizing hormone (LH) in human serum. This assay is useful in the diagnosis and treatment of gonadal dysfunction....
... (LH) is a glycoprotein secreted by the ... and TSH, the intact LH molecule is ... These glycoproteins all have homologous alpha-subunits, however ... LH and FSH production and secretion are ...
The NPT7 blood gas analyzer measures pH/blood gases and oximetry on 90 L sample volume with a two-step sampling procedure. Clinical tests compare NPT7 accuracy to that of benchtop analyzers. 30 sampl...
Medicine Products: